Yahoo Finance 
The Trout Group to Host a "TroutTalk" Key Opinion Leader Discussion on June 24th in San Francisco
Dr. Crystal Mackall, Associate Director of the Stanford Cancer Institute and Co-Medical Director of the Stanford Laboratory for Cell and Gene Medicine, Will Discuss Cancer Immunotherapy in the Pediatric Setting
SAN FRANCISCO, CA--(Marketwired - June 23, 2016) - The Trout Group, the leading global investor relations and strategic advisory firm servicing the life sciences industry, announced that it will host its 36th Trout Talk on June 24th in San Francisco. Trout Talks is an ongoing seminar series highlighting the technologies of cancer immunotherapy.
The invited speaker for this event, Dr. Crystal Mackall, is an internationally recognized pediatric oncologist, specializing in the use of cancer immunotherapies in children, including the design and clinical application of chimeric antigen receptor (CAR) T-cell therapy. Mackall, who previously headed the Immunology Section at the National Cancer Institute in Bethesda, Maryland, and served as chief of the Institute's Pediatric Oncology Branch is now leading Stanford's efforts to advance clinical trials of immune therapies for cancer, with the ultimate goal of moving them to widespread clinical use.
Mackall also serves as co-leader of Stand Up 2 Cancer's Pediatric Cancer Dream Team, a multi-institutional program focused on developing novel immunotherapies for childhood cancer.
She holds patents or has patents pending for nine advances in cancer immune therapy.
The talk will be moderated by Bloomberg Intelligence's biotechnology analyst Asthika Goonewardene and will take place on Friday, June 24th from 12:00pm-1:30pm at Bloomberg's offices in San Francisco. It will consist of a 30 minute formal presentation followed by 30 minutes for questions from the audience. A live webcast of the event will be available at www.bloomberglp.com/immuno-oncology.
About The Trout Group:
Since 1996, Trout has been the leading strategic partner to the life sciences industry, connecting companies, investors and the most exciting innovations in the sector. With a unique suite of services in investor relations, communications and financial advisory, Trout is at the intersection through which scientific advances and its network of powerful relationships can meet to create long term value for stakeholders.
